Bionano Genomics Inc BNGO

NAS: BNGO | ISIN: US09075F1075   1/05/2025
4,000 USD (+0,25%)
(+0,25%)   1/05/2025
Grafiek Bionano Genomics Inc Grafiek Bionano Genomics Inc

Bionano Genomics Inc in het nieuws

15 maart 2021 · Bionano Genomics to Present at Several Upcoming Investor Conferences · Persbericht

10 maart 2021 · Bionano Genomics Presented at H.C. Wainwright Global Life Sciences Conference · Persbericht

9 maart 2021 · Bionano Genomics to Report Fourth Quarter and Year End 2020 Financial Results and Host a Conference Call and Webcast on March 23rd, 2021 · Persbericht

3 maart 2021 · Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr · Persbericht

2 maart 2021 · Bionano Genomics to Present at the Cowen 41st Annual Health Care Conference · Persbericht

1 maart 2021 · Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer · Persbericht

25 februari 2021 · Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed · Persbericht

11 februari 2021 · Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference · Persbericht

5 februari 2021 · Presentation Recordings from Bionano’s Next-Generation Cytogenomics Symposium, its Most Attended Event to Date, Now Available Online · Persbericht

29 januari 2021 · Dr. Gordana Raca from Children’s Hospital Los Angeles Presents Findings That Show Saphyr Detects Druggable Gene Fusions in Pediatric Acute Leukemias that NGS and Cytogenetics Missed · Persbericht

Profiel Bionano Genomics Inc

Biotechnologie
Gezondheidstechnologie
Professionele, wetenschappelijke en technische diensten
Testlaboratoria

Website: bionanogenomics.com

Hoofdzetel: San Diego, California vlag Verenigde Staten

CEO: R. Erik Holmlin

Werknemers: 313

Mijn selecties